SCHEMBL8799589

SCHEMBL8799589

Cc1cccc(Nc2cc(N3CC(C)OC(C)C3)ncn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TNNI3K Q59H18 2/20 0.46
▸ SCN9A Q15858 3/20 0.44
▸ LMNA P02545 2/20 0.43
▸ MAPK10 P53779 2/20 0.43
▸ GAA P10253 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ POLB P06746 2/20 0.41
▸ KDR P35968 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ LRRK2 Q5S007 2/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ PRKDC P78527 1/20 0.39
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8799584 1.00 EGFR (0.47) EGFRMEN1KMT2ATNNI3KSCN9A
SCHEMBL8314329 0.85 EGFR (0.49) EGFRMEN1KMT2ATNNI3KSCN9A
SCHEMBL8800521 0.79 EGFR (0.50) EGFRMEN1KMT2ATNNI3KSCN9A
SCHEMBL8805243 0.79 EGFR (0.55) EGFRTNNI3KSCN9AKDR
SCHEMBL8315857 0.77 EGFR (0.49) EGFRKMT2ATNNI3KSCN9ALMNA
SCHEMBL27323457 0.76 EGFR (0.53) EGFRTNNI3KSCN9ALMNAMAPK10
SCHEMBL1387302 0.76 EGFR (0.72) EGFRMEN1KMT2ATNNI3KMAPK1
SCHEMBL8317533 0.75 EGFR (0.46) EGFRMEN1KMT2ATNNI3KSCN9A
SCHEMBL8798398 0.75 SCN9A (0.48) EGFRTNNI3KSCN9AMAPK10USP2
SCHEMBL8799311 0.75 EGFR (0.52) EGFRKMT2ATNNI3KSCN9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779888-A1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1997-06-25 — — EP disclosed
WO-1996007657-A1 PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1996-03-14 — — WO disclosed
Send feedback